1993
DOI: 10.1016/s0002-9394(14)71452-7
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Insulin Therapy on Progression of Retinopathy in Noninsulin-dependent Diabetes Mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
23
0
2

Year Published

1995
1995
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(29 citation statements)
references
References 13 publications
3
23
0
2
Order By: Relevance
“…This was reported in several large studies [1,2,3,4] and was confirmed in the Diabetes Control and Complications Trial (DCCT) [5,6,7]. The DCCT study showed deterioration of retinopathy in patients with Type 1 diabetes during the first 3 to 12 months with intensive therapy, followed by a beneficial effect, which increased in magnitude over time.…”
Section: Introductionmentioning
confidence: 53%
“…This was reported in several large studies [1,2,3,4] and was confirmed in the Diabetes Control and Complications Trial (DCCT) [5,6,7]. The DCCT study showed deterioration of retinopathy in patients with Type 1 diabetes during the first 3 to 12 months with intensive therapy, followed by a beneficial effect, which increased in magnitude over time.…”
Section: Introductionmentioning
confidence: 53%
“…A pathologic role for insulin is supported by the finding that pre-diabetic hyperinsulinemia contributes to glomerular hypertrophy (51). Elevated insulin levels that occur with intensive insulin therapy in type 1 or type 2 diabetes have been associated with transient worsening of diabetic retinopathy (52,53); similarly, short-term peaks in insulin may stimulate laminin-␤1 mRNA translation in renal epithelial cells. Thus, recurrent episodes of high glucose and high insulin may stimulate synthesis of small amounts of laminin-␤1, which over time may contribute to significant expansion of matrix in the kidney in type 2 diabetes.…”
Section: Discussionmentioning
confidence: 99%
“…For CSMT, group 1 tended to have a greater HbA1c reduction (−2.9% vs −1.2% of THb, p=0.074) than group Introduction Improvement of glycemic control reduced the risk of development and progression of diabetic retinopathy [1,2]. However, paradoxical worsening of retinopathy after rapid improvement of blood glucose level in both type 1 and type 2 diabetes was also reported in several literatures [3][4][5][6][7][8][9][10][11]. The Diabetes Control and Complication Trial (DCCT) demonstrated that early worsening of retinopathy was observed at 6-and 12-month visits in 13.1% of patients assigned to intensive treatment, and in 7.6% of patients assigned to conventional treatment.…”
Section: Abstractsmentioning
confidence: 99%